| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.1739 | 21618577
|
| GPC3 | 4451 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.0032 | 21618577
|
| KIT | 6342 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.018 | 21618577
|
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.5461 | 21618577
|
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.6448 | 21618577
|
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.7582 | 21618577
|
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.5695 | 21618577
|
| AAMP | 18 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ABCB1 | 40 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0604 | 21618577
|
| ABHD8 | 23759 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ACOT11 | 18156 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ACTN4 | 166 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| ADAM17 | 195 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ADAM22 | 201 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ADAMTS1 | 217 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ADAMTSL3 | 14633 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| AGGF1 | 24684 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| AGT | 333 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| AHDC1 | 25230 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| AKAP1 | 367 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| AKR1B10 | 382 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| AKR1C4 | 387 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ALG13 | 30881 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ALKBH8 | 25189 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ALPK2 | 20565 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| AMD1 | 457 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| AMDHD1 | 28577 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ANKFY1 | 20763 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ANKRD10 | 20265 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ANKRD50 | 29223 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ANP32A | 13233 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ANXA6 | 544 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| AP2B1 | 563 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| APEH | 586 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| APOBEC3B | 17352 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| APOC1 | 607 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| AR | 644 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ARC | 648 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ARHGAP32 | 17399 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ARHGEF10 | 14103 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ARHGEF12 | 14193 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ARHGEF19 | 26604 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ARL9 | 23592 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ARMT1 | 17872 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ARRDC3 | 29263 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ASGR1 | 742 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ASPHD1 | 27380 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ASRGL1 | 16448 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| ATAT1 | 21186 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ATM | 795 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| AXIN2 | 904 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| B4GALT5 | 928 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| BAAT | 932 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| BAX | 959 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| BCAP29 | 24131 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| BCL2L15 | 33624 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| BHLHB2 | 1046 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| BHLHB9 | 29353 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| BOLA1 | 24263 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| BORA | 24724 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| BRWD1 | 12760 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| C10ORF35 | 23519 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C12ORF34 | 25915 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C12ORF60 | 28726 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C15ORF29 | 26199 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C18ORF54 | 13796 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| C1GALT1 | 24337 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| C1ORF109 | 26039 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C1ORF54 | 26258 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| C3ORF14 | 25024 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C3ORF23 | 25241 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| C9ORF152 | 31455 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CAPN15 | 11182 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CAPRIN2 | 21259 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CASP1 | 1499 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CAV1 | 1527 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0117 | 21618577
|
| CBX3 | 1553 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CCDC183 | 28236 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CCL20 | 10619 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| CCN3 | 7885 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CCND1 | 1582 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0201 | 21618577
|
| CDC2 | 1722 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| CDC34 | 1734 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CDC42BPB | 1738 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CDC42EP1 | 17014 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CDH15 | 1754 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CDKN1C | 1786 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CDKN2B | 1788 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CDRT4 | 14383 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CEBPD | 1835 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| CELSR2 | 3231 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CENPA | 1851 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| CFAP53 | 26530 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CGN | 17429 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CHAC2 | 32363 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CHPT1 | 17852 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CHST13 | 21755 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CITED1 | 1986 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CKAP2 | 1990 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CKAP2L | 26877 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CLDN15 | 2036 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CLDN2 | 2041 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CLRN3 | 20795 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CNOT6 | 14099 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| COL15A1 | 2192 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| COL18A1 | 2195 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| COL4A5 | 2207 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| COMMD8 | 26036 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| COPZ2 | 19356 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| COX11 | 2261 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| COX19 | 28074 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CPEB2 | 21745 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CSF2RA | 2435 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CSGALNACT1 | 24290 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| CSPP1 | 26193 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CTAG2 | 2492 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CTRL | 2524 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CUTC | 24271 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| CX3CL1 | 10647 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| CXCL2 | 4603 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| CYP3A5 | 2638 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| CYSRT1 | 30529 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DAPK1 | 2674 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| DBF4 | 17364 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DCAF13 | 24535 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| DCLRE1B | 17641 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DDIT4 | 24944 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DDR1 | 2730 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| DDR2 | 2731 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| DENND5B | 28338 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DFFA | 2772 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DGCR8 | 2847 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DHRS1 | 16445 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DIPK2A | 28490 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DLEU1 | 13747 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DMBT1 | 2926 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DNPH1 | 21218 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DTL | 30288 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| DTNA | 3057 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| DUSP10 | 3065 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DYNC1H1 | 2961 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| DYNC1LI1 | 18745 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| DYNC2I1 | 21862 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ECM2 | 3154 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| EDARADD | 14341 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EDN1 | 3176 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| EDN2 | 3177 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| EEA1 | 3185 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| EEF1A2 | 3192 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| EEF2K | 24615 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EHF | 3246 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| EIF2B4 | 3260 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EIF4E | 3287 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ELFN2 | 29396 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ELFN2 | 29396 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ELP1 | 5959 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| EMG1 | 16912 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ENKD1 | 25246 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EP400 | 11958 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| EPGN | 17470 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| EPM2AIP1 | 19735 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ERN1 | 3449 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ESAM | 17474 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EVA1A | 25816 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| EXPH5 | 30578 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| F8A1 | 3547 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| F8A1 | 31849 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| F8A1 | 31850 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| FABP6 | 3561 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FAHD2A | 24252 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FAM102B | 27637 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| FAM167A | 15549 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FAM69B | 28290 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FAM72D | 33593 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FAM81A | 28379 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FAM83B | 21357 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| FAM98B | 26773 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FBXO32 | 16731 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FCHO1 | 29002 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FES | 3657 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FGD3 | 16027 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FGF13 | 3670 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FGF2 | 3676 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| FGG | 3694 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FHDC1 | 29363 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FKBP4 | 3720 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FKBP4 | 13949 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| FLRT3 | 3762 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| FMO3 | 3771 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FOLR1 | 3791 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| FOXA2 | 5022 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| FSD1 | 13745 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GALNT11 | 19875 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GAS2L3 | 27475 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GATA2 | 4171 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GBP2 | 4183 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GCNT3 | 4205 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GDA | 4212 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| GHR | 4263 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GKAP1 | 17496 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GLB1 | 4298 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GLRX3 | 15987 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| GLT8D2 | 24890 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GMIP | 24852 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GMPPB | 22932 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GNAL | 4388 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GNGT1 | 4411 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GNPTG | 23026 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GNRH1 | 4419 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GPR87 | 4538 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| GPX3 | 4555 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| GRIK2 | 4580 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| GSG1L | 28283 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GSPT2 | 4622 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| GTF2H2 | 4656 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GTF2H2 | 31394 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| GTPBP8 | 25007 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| GUSB | 4696 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| H19 | 4713 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| H2AC8 | 4724 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| HADH | 4799 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HADHA | 4801 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| HAUS1 | 25174 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HCG27 | 27366 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HCG9 | 21243 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HERC2 | 4868 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HIKESHI | 26938 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HJURP | 25444 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HLA-DMA | 4934 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HLA-F | 4963 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HLA-G | 4964 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HMGCR | 5006 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| HNRPLL | 25127 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HOMER3 | 17514 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HOXA13 | 5102 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HOXC9 | 5130 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HRK | 5185 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HRSP12 | 16897 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| HS1BP3 | 24979 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HSCB | 28913 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| HSPE1 | 5269 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| ICAM1 | 5344 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| IER3 | 5392 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| IFI16 | 5395 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| IFI6 | 4054 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| IFITM1 | 5412 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| IL24 | 11346 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| IL6 | 6018 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0191 | 21618577
|
| IL8 | 6025 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577
|
| ING2 | 6063 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| INHBB | 6067 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| INHBE | 24029 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| INTS13 | 20174 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| INTS3 | 26153 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| INTS6 | 14879 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ITGA6 | 6142 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0265 | 21618577
|
| ITGB5 | 6160 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ITSN2 | 6184 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| IVNS1ABP | 16951 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KBTBD8 | 30691 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KCNH2 | 6251 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KIAA0256 | 28997 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KIAA2026 | 23378 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KIF1B | 16636 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KIFAP3 | 17060 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| KLF9 | 1123 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| KLHL11 | 19008 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KLHL15 | 29347 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| KLHL23 | 27506 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| KLKB1 | 6371 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KMT2C | 13726 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| KNSTRN | 30767 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| KRT16 | 6423 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| KRT19 | 6436 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| KRTDAP | 16313 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LAMA1 | 6481 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LDAF1 | 30136 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LGR4 | 13299 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| LHX4 | 21734 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LIG1 | 6598 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LIPT1 | 29569 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LRBA | 1742 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LRCH1 | 20309 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LRIG1 | 17360 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| LRMDA | 23405 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LRRC45 | 28302 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LSM5 | 17162 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LSM6 | 17017 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| LSS | 6708 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| LTO1 | 17589 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| LYPD6 | 28751 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MAF | 6776 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MAFB | 6408 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MAGEA1 | 6796 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MAP3K4 | 6856 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MAP3K8 | 6860 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MAP7D2 | 25899 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MAPK8 | 6881 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MAPKAPK3 | 6888 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MARK2 | 3332 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MATK | 6906 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MB21D2 | 30438 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MBD2 | 6917 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MBTPS1 | 15456 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MC1R | 6929 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MCFD2 | 18451 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MCTP1 | 26183 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MDN1 | 18302 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ME1 | 6983 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| MED12 | 11957 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MED21 | 11473 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MED9 | 25487 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MEMO1 | 14014 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| METTL5 | 25006 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| METTL6 | 28343 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MFNG | 7038 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MGARP | 29969 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MIX23 | 31136 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MMP23B | 7171 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MMP25 | 14246 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MND1 | 24839 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MPHOSPH6 | 7214 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MPI | 7216 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MPP7 | 26542 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MPV17 | 7224 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MRPL33 | 14487 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MRPL47 | 16652 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MRPL48 | 16653 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MSRB3 | 27375 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MTHFD2 | 7434 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| MXD1 | 6761 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MYO9A | 7608 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| MYPN | 23246 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| MYRF | 1181 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| N4BP1 | 29850 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NAB1 | 7626 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NACA4P | 24688 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NCOA2 | 7669 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| NDUFAF4 | 21034 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NDUFS6 | 7713 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NEURL4 | 34410 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| NF1 | 7765 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| NFIB | 7785 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| NIBAN1 | 16784 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| NME6 | 20567 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NMRK1 | 26057 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NMRK2 | 17871 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NOD1 | 16390 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NOG | 7866 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NOL12 | 28585 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NPNT | 27405 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| NPTX1 | 7952 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| NR2F2 | 7976 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NR4A1 | 7980 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| NRTN | 8007 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NSUN6 | 23529 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| NUAK2 | 29558 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NUDT6 | 8053 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| NUP214 | 8064 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| NUP35 | 29797 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| OLR1 | 8133 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| ORM1 | 8498 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ORMDL1 | 16036 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| OSCP1 | 29971 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| OTUD4 | 24949 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| P2RY11 | 8540 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PAK1IP1 | 20882 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PAQR5 | 29645 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PAQR9 | 30131 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PARP4 | 271 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PAX9 | 8623 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PBX1 | 8632 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| PCCA | 8653 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PCDH20 | 14257 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| PCDHB17P | 14547 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PCDHB2 | 8687 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PCDHB2 | 8688 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PCGF6 | 21156 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PCSK6 | 8569 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PDE7B | 8792 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PDGFRA | 8803 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PDZD2 | 18486 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PEA15 | 8822 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PFN2 | 8882 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PGM2L1 | 20898 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PLAC8 | 19254 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PLCXD3 | 31822 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PMAIP1 | 9108 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PNPLA7 | 24768 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| POLR1G | 24219 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| POLR3C | 30076 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| POLR3G | 30075 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| POM121 | 19702 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PPIP5K1 | 29023 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PPP1R15A | 14375 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PPP1R3C | 9293 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PPP2R2D | 23732 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PROSER2 | 23728 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PRRX1 | 9142 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PRSS53 | 34407 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PRTFDC1 | 23333 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| PSCA | 9500 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| PSMC6 | 9553 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| PSTK | 28578 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| PYROXD2 | 23517 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| R3HDM1 | 9757 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RAB11A | 9760 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RAB3IL1 | 9780 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RAB40B | 18284 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RAB6A | 9786 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RAPGEF6 | 20655 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RBBP6 | 9889 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| REEP2 | 17975 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| REV3L | 9968 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| REXO4 | 12820 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RFESD | 29587 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RFPL3S | 9981 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RGR | 9990 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RGS12 | 9994 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RHBDF2 | 20788 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RHOB | 668 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| RICTOR | 28611 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RILPL1 | 26814 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RIPK3 | 10021 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RIPK4 | 496 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RIPOR1 | 25836 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RN7SK | 10037 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RNASEH1 | 18466 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RNASEH2B | 25671 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RNASEH2C | 24116 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RND1 | 18314 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RNF111 | 17384 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RNF125 | 21150 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RNF144B | 21578 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| RNF149 | 23137 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RNFT1 | 30206 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RNLS | 25641 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RPL36A | 10359 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RPL6 | 10362 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| RPS7 | 10440 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| RRAGB | 19901 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RRM2 | 10452 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RRP9 | 16829 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| RTL8C | 2569 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| RUNX1 | 10471 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| S100A7L2 | 21655 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SC5DL | 10547 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SCIN | 21695 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| SCNN1D | 10601 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SEC16A | 29006 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SECISBP2 | 30972 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SELL | 10720 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SERPINE1 | 8583 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| SERTAD4 | 25236 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SESN1 | 21595 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SF3B6 | 30096 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SFXN2 | 16086 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SGSH | 10818 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SH2D4A | 26102 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| SH3BGRL2 | 15567 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SH3BP5L | 29360 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SHOC1 | 26535 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SHPK | 1492 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SKAP2 | 15687 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SLC17A3 | 10931 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SLC22A23 | 21106 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SLC25A19 | 14409 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SLC35F6 | 26055 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SLC39A8 | 20862 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SLC47A1 | 25588 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| SLC49A4 | 16628 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SLC6A12 | 11045 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| SLC7A8 | 11066 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| SLC9B2 | 25143 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SMAD6 | 6772 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| SMAP1 | 19651 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SMC1A | 11111 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SMG9 | 25763 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SNAI2 | 11094 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577
|
| SNAP23 | 11131 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SND1 | 30646 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SND1-IT1 | 24158 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SNHG5 | 21026 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SNORA25 | 32615 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SNX24 | 21533 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SOCS4 | 19392 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SOX4 | 11200 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| SOX9 | 11204 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0244 | 21618577
|
| SPAG1 | 11212 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SPATA2 | 14681 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SPG11 | 11226 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SPRR1B | 11260 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| SPRY4 | 15533 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SPTSSA | 20361 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| SPTSSB | 24045 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SRPK2 | 11306 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SSH2 | 30580 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| SSX1 | 11335 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| STEAP2 | 17885 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| STX11 | 11429 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| SYNGR4 | 11502 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TAF1A | 11532 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TAF5L | 17304 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TAF9 | 11542 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TAS2R14 | 14920 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| TAS2R5 | 14912 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TATDN1 | 24220 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TATDN3 | 27010 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TAX1BP3 | 30684 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TCEA3 | 11615 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TDP2 | 17768 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TENT5A | 18345 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TFF2 | 11756 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TFF3 | 11757 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
| TFR2 | 11762 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TICRR | 28704 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TIMP4 | 11823 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TLE6 | 30788 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TM4SF5 | 11857 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TMBIM1 | 23410 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TMED10 | 16998 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TMEM126B | 30883 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TMEM128 | 28201 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TMEM131L | 29146 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TMEM256 | 28618 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TMEM268 | 24513 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TMEM79 | 28196 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TNFAIP3 | 11896 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
| TNFRSF11B | 11909 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| TNFRSF12A | 18152 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TNFRSF13C | 17755 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TNIK | 30765 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
| TNKS1BP1 | 19081 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TOX2 | 16095 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TPP1 | 2073 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TPR | 12017 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| TPRKB | 24259 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TPST1 | 12020 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TRAF7 | 20456 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TRAPPC2 | 23068 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TRIM29 | 17274 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
| TRIM37 | 7523 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TRIM4 | 16275 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TRIM7 | 16278 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TRMT61B | 26070 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TRPV2 | 18082 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TSPAN10 | 29942 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TTC12 | 23700 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TTC27 | 25986 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TTC3 | 12393 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TTLL3 | 24483 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| TXNDC16 | 19965 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| TXNDC9 | 24110 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| TYSND1 | 28531 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UBA2 | 30661 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| UBAP2L | 29877 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UBE2Q2 | 19248 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UBE3D | 21381 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UBXN2A | 27265 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UCN | 12516 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UGT1A1 | 12530 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| UGT1A10 | 12531 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| UMPS | 12563 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| UQCR11 | 30862 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| VAMP1 | 12642 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| VCX3B | 31838 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| VGF | 12684 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| VPS37D | 18287 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| VRK2 | 12719 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| VWA1 | 30910 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| WEE1 | 12761 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| YPEL2 | 18326 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| YTHDC1 | 30626 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZBTB20 | 13503 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZBTB5 | 23836 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZBTB8OS | 24094 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZC3H12A | 26259 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZC3H8 | 30941 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZCWPW1 | 23486 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZFC3H1 | 28328 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZFYVE21 | 20760 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZFYVE26 | 20761 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF121 | 12904 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF140 | 12925 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ZNF17 | 12958 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF271P | 13065 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF295-AS1 | 23130 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF304 | 13505 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF324 | 14096 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF33B | 13097 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF35 | 13099 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF385B | 26332 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF397 | 18818 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ZNF417 | 20646 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF443 | 20878 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF543 | 25281 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF580 | 29473 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF581 | 25017 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF585A | 26305 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF627 | 30570 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF630 | 28855 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF671 | 26279 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF695 | 30954 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
| ZNF740 | 27465 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF75A | 13146 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
| ZNF771 | 29653 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF777 | 22213 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF784 | 33111 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF805 | 23272 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF81 | 13156 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZNF875 | 4928 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
| ZP3 | 13189 | HTM | Hepatic Cancer | Carcinoma | KMCH-1 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|